Audit Finding: Third-Party SOPs

Compliance Risks When Contract Manufacturer SOPs Are Not Integrated into Site QMS

Compliance Risks When Contract Manufacturer SOPs Are Not Integrated into Site QMS Integrating Third-Party SOPs into the Pharmaceutical Site QMS Introduction to the Audit Finding 1. Overview of Third-Party Manufacturing Many pharmaceutical companies rely on contract manufacturers (CMOs) to perform GMP-critical operations. However, the originating company remains fully responsible for ensuring compliance across the product…

GMP Audit Findings, Third-Party SOPs

Audit Risk: Absence of SOPs for Contract Manufacturing Oversight

Audit Risk: Absence of SOPs for Contract Manufacturing Oversight Contract Manufacturing Oversight Lapses: The Risk of Missing Oversight SOPs Introduction to the Audit Finding 1. Audit Observation Overview Pharmaceutical firms outsourcing operations to Contract Manufacturing Organizations (CMOs) often fail to maintain internal SOPs for oversight and governance. 2. GMP Oversight Is Mandatory Even when operations…

GMP Audit Findings, Third-Party SOPs

Ensuring Integration of Third-Party SOPs into Internal Quality Systems

Ensuring Integration of Third-Party SOPs into Internal Quality Systems Bridging the SOP Gap Between Contract Manufacturers and Internal GMP Systems Introduction to the Audit Finding 1. The Outsourcing Challenge Many pharmaceutical companies outsource manufacturing to contract facilities. However, failure to integrate their SOPs into the internal Quality Management System (QMS) can lead to serious GMP…

GMP Audit Findings, Third-Party SOPs

Addressing Oversight Failures in Third-Party SOP Compliance

Addressing Oversight Failures in Third-Party SOP Compliance Improving Oversight of Third-Party SOP Compliance in GMP Operations Introduction to the Audit Finding 1. What the Issue Involves This audit finding pertains to inadequate internal oversight of Standard Operating Procedures (SOPs) at third-party sites such as contract manufacturers (CMOs), laboratories, or packagers. 2. GMP Accountability Still Rests…

GMP Audit Findings, Third-Party SOPs

Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates

Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates Establishing Robust Procedures for Vendor SOP Updates Review in GMP Systems Introduction to the Audit Finding 1. The Gap Explained This audit finding highlights the absence of a documented process for reviewing updated SOPs received from vendors or third-party service providers. 2. GMP Relevance In…

GMP Audit Findings, Third-Party SOPs

Resolving SOP Discrepancies Between Sponsors and Contract Labs in Analytical Testing

Resolving SOP Discrepancies Between Sponsors and Contract Labs in Analytical Testing Managing Analytical Testing SOP Discrepancies Between Sponsor and Contract Laboratories Introduction to the Audit Finding 1. What the Finding Means This issue arises when the sponsor’s internal SOPs for analytical testing differ from those used by the contract lab performing critical analyses on their…

GMP Audit Findings, Third-Party SOPs

Ensuring SOP Alignment with Outsourced Logistics Providers for GMP Compliance

Ensuring SOP Alignment with Outsourced Logistics Providers for GMP Compliance Bridging SOP Gaps with Outsourced Logistic Partners in Pharma Distribution Introduction to the Audit Finding 1. What Was Observed During GMP inspections, it is frequently noted that pharmaceutical companies fail to share critical SOPs with their third-party logistics (3PL) providers. 2. Why It Matters When…

GMP Audit Findings, Third-Party SOPs